Search details
1.
Chrononutrition in the context of Ramadan: Potential implications.
Diabetes Metab Res Rev
; 40(2): e3728, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37830266
2.
Alterations in ß-Cell Sphingolipid Profile Associated with ER Stress and iPLA2ß: Another Contributor to ß-Cell Apoptosis in Type 1 Diabetes.
Molecules
; 26(21)2021 Oct 21.
Article
in English
| MEDLINE | ID: mdl-34770770
3.
Calcium-independent phospholipases A2 and their roles in biological processes and diseases.
J Lipid Res
; 56(9): 1643-68, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26023050
4.
Ramadan Fasting and Changes in Thyroid Function in Hypothyroidism: Identifying Patients at Risk.
Thyroid
; 32(4): 368-375, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35152772
5.
Diabetes and Ramadan: Practical guidelines 2021.
Diabetes Res Clin Pract
; 185: 109185, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35016991
6.
Ramadan fasting in insulin-treated patients is associated with potentially unfavourable changes in glucose metrics: A flash glucose monitoring (FGM) study.
Diabetes Res Clin Pract
; 172: 108592, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33310126
7.
Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency.
Front Endocrinol (Lausanne)
; 12: 792354, 2021.
Article
in English
| MEDLINE | ID: mdl-35095762
8.
Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate.
Biomolecules
; 10(10)2020 09 23.
Article
in English
| MEDLINE | ID: mdl-32977496
9.
Energy Metabolism and Intermittent Fasting: The Ramadan Perspective.
Nutrients
; 11(5)2019 May 27.
Article
in English
| MEDLINE | ID: mdl-31137899
10.
Diabetes and Ramadan: Utility of flash-glucose monitoring derived markers of glycaemic control and comparison with glycosylated haemoglobin.
Diabetes Res Clin Pract
; 153: 150-156, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31150718
11.
Selenium stimulates pancreatic beta-cell gene expression and enhances islet function.
FEBS Lett
; 582(15): 2333-7, 2008 Jun 25.
Article
in English
| MEDLINE | ID: mdl-18538137
12.
Inhibition of Ca2+-independent phospholipase A2ß (iPLA2ß) ameliorates islet infiltration and incidence of diabetes in NOD mice.
Diabetes
; 64(2): 541-54, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25213337
13.
Evidence of contribution of iPLA2ß-mediated events during islet ß-cell apoptosis due to proinflammatory cytokines suggests a role for iPLA2ß in T1D development.
Endocrinology
; 155(9): 3352-64, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25004092
14.
Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2ß): candidate drug for preventing beta-cell apoptosis and diabetes.
PLoS One
; 8(8): e71748, 2013.
Article
in English
| MEDLINE | ID: mdl-23977134
15.
Genetic modulation of islet ß-cell iPLA2ß expression provides evidence for its impact on ß-cell apoptosis and autophagy.
Islets
; 5(1): 29-44, 2013.
Article
in English
| MEDLINE | ID: mdl-23411472
16.
Tumor suppressor Pdcd4 is a major transcript that is upregulated during in vivo pancreatic islet neogenesis and is expressed in both beta-cell and ductal cell lines.
Pancreas
; 40(1): 61-6, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20871477
Results
1 -
16
de 16
1
Next >
>>